Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

A-18 Novel Method to Produce Mesenchymal Stem Cells


技術優勢

ΓùÅ Novel: This is a novel method to isolate ADSCs from adipose cellsΓùÅ Patient-Friendly: ADSCs can be produced from patientΓÇÖs own embryo or skin cellsΓùÅ Diversified Applications: ADSCs can be differentiated into adipose, osteoblast, skeletal muscle and chondrocytes.


技術應用

ΓùÅ Regenerative medicine (adipose, osteoblast, skeletal muscle and chondrocyte)ΓùÅ Transplantation for arterial sclerosis, cardial infarcts, hepatocirrhosis, diabetes, ParkinsonΓÇÖs disease and muscular dystrophy patientsΓùÅ Research tools for lab technicians


詳細技術說明

None


附加資料

Inventor: TORIHASHI, Shigeko | NINAGAWA, Nana
Priority Number: WO2009128533A1
IPC Current: C12N00050775 | C12N000510
Assignee Applicant: National University Corporation Nagoya University
Title: MESENCHYMAL STEM CELL AND METHOD FOR PRODUCTION THEREOF | CELLULE SOUCHE MÉSENCHYMATEUSE ET SON PROCÉDÉ DE PRODUCTION
Usefulness: MESENCHYMAL STEM CELL AND METHOD FOR PRODUCTION THEREOF | CELLULE SOUCHE MÉSENCHYMATEUSE ET SON PROCÉDÉ DE PRODUCTION
Summary: The cell culture product is useful in regeneration medicine for treating diseases such as life-style related diseases, e.g. arteriosclerosis, myocardial infarction, liver cirrhosis, diabetes, Parkinson's disease and muscular dystrophy.
Novelty: Cell culture product in regeneration medicine for treating diseases e.g. diabetes, comprises mesenchymal stem cell of cluster of differentiation 105 positive cell differentiated from pluripotent stem cell derived from human or animal


主要類別

生物醫學


細分類別

生物工程


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版